Literature DB >> 18467878

Human papillomavirus (HPV) type distribution in Korean women: a meta-analysis.

Jeong-Hoon Bae1, Sung-Jong Lee, Chan-Joo Kim, Soo-Young Hur, Yong-Gyu Park, Won-Chul Lee, Young-Tak Kim, Timothy L Ng, Hans L Bock, Jong-Sup Park.   

Abstract

The aim of the present study is to estimate the overall prevalence and type distribution of human papillomavirus (HPV) in Korean women, through literature review and meta-analysis. We searched published data for the period between 1995 and 2007 using the following inclusion criteria; (1) studies using type-specific HPV tests, (2) data from Korean female, (3) with cytologic or pathologic results, (4) having more than 20 cases for each subgroup classified by cytologic results, and (5) HPV detection including types 16, 18, and at least one other type. In total, 18 studies (13,842 cases) published up to April 2007 were identified and selected. Adjusted overall HPV prevalence was 23.9% (95% CI: 23.8-24.1%) in women with normal cytology and 95.8% (95% CI: 95.4-96.2%) in women with cervical cancer. Type 16 was predominant regardless of cervical disease status, and type 58 occupied a significantly larger proportion in high-grade cervical intraepithelial lesions and cervical cancer in Korean women. HPV types 58, 33, and 52 together accounted for about 20% of infections in cervical cancer and high-grade intraepithelial lesions. After introduction of HPV prophylactic vaccines, extended protection, especially against types 58, 33, and 52, will be an important issue for cervical cancer prevention in Korea. The future dominant genotypes will require follow-up epidemiological studies with a large-scale, multicentered, and prospective design.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18467878

Source DB:  PubMed          Journal:  J Microbiol Biotechnol        ISSN: 1017-7825            Impact factor:   2.351


  22 in total

1.  Type-specific persistence or regression of human papillomavirus genotypes in women with cervical intraepithelial neoplasia 1: A prospective cohort study.

Authors:  Hyun Woong Cho; Kyeong A So; Jae Kwan Lee; Jin Hwa Hong
Journal:  Obstet Gynecol Sci       Date:  2015-01-16

2.  Expression of Müllerian inhibiting substance type II receptor and antiproliferative effects of MIS on human cervical cancer.

Authors:  Jae Yen Song; Hyun Hee Jo; Mee Ran Kim; Young Oak Lew; Ki Sung Ryu; Jung Ho Cha; Chang Suk Kang; Patricia K Donahoe; David T MacLaughlin; Jang Heub Kim
Journal:  Int J Oncol       Date:  2012-02-14       Impact factor: 5.650

3.  Prevalence of human papillomavirus infection and genotype distribution among high-risk Korean women for prospecting the strategy of vaccine development.

Authors:  Jee Eun Rhee; Mi Yeong Shin; Choong Mo Kim; Hye Young Kee; Jae Keun Chung; Sang-Kee Min; Seong-Joon Kim; Dai-Ho Jang; Sung Soon Kim; Byeong-Sun Choi
Journal:  Virol J       Date:  2010-08-25       Impact factor: 4.099

4.  Vaccination with a human papillomavirus (HPV)-16/18 AS04-adjuvanted cervical cancer vaccine in Korean girls aged 10-14 years.

Authors:  Young-Jae Kim; Kyung-Tai Kim; Jae-Hoon Kim; Soon-Do Cha; Jae Weon Kim; Duk-Soo Bae; Joo-Hyun Nam; Woong-Shick Ahn; Ho-Sun Choi; Timothy Ng; Dan Bi; Jin-Ju OK; Dominique Descamps; Hans L Bock
Journal:  J Korean Med Sci       Date:  2010-07-21       Impact factor: 2.153

5.  Current status of cervical cancer and HPV infection in Korea.

Authors:  Young-Tak Kim
Journal:  J Gynecol Oncol       Date:  2009-03-31       Impact factor: 4.401

6.  The increasing frequency of cervical cancer in Korean women under 35.

Authors:  Chan Hee Han; Hyun Jung Cho; Sung Jong Lee; Jeong Hoon Bae; Seog Nyen Bae; Sung Eun Namkoong; Jong Sup Park
Journal:  Cancer Res Treat       Date:  2008-03-31       Impact factor: 4.679

7.  Prevalence of human papillomavirus infection and genotype distribution determined by the cyclic-catcher melting temperature analysis in Korean medical checkup population.

Authors:  Yun-Jee Kim; Min-Jung Kwon; Hee-Yeon Woo; Soon-Young Paik
Journal:  J Microbiol       Date:  2013-09-14       Impact factor: 3.422

Review 8.  Human papillomavirus related cervical cancer and anticipated vaccination challenges in Ethiopia.

Authors:  TeweldeTesfaye Gebremariam
Journal:  Int J Health Sci (Qassim)       Date:  2016-01

9.  Human papillomavirus 16/18 AS04-adjuvanted cervical cancer vaccine: immunogenicity and safety in 15-25 years old healthy Korean women.

Authors:  Seung Cheol Kim; Yong Sang Song; Young-Tae Kim; Young Tak Kim; Ki-Sung Ryu; Bhavyashree Gunapalaiah; Dan Bi; Hans L Bock; Jong-Sup Park
Journal:  J Gynecol Oncol       Date:  2011-06-30       Impact factor: 4.401

10.  Genetic variability in L1 and L2 genes of HPV-16 and HPV-58 in Southwest China.

Authors:  Yaofei Yue; Hongying Yang; Kun Wu; Lijuan Yang; Junying Chen; Xinwei Huang; Yue Pan; Youqing Ruan; Yujiao Zhao; Xinan Shi; Qiangming Sun; Qihan Li
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.